FDA Inspection 1092492 — Czeslaw Marcisz, M.D., Clinical Investigator
The FDA completed an inspection of Czeslaw Marcisz, M.D., Clinical Investigator on May 17, 2019 in Tychy. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tychy (Poland)
Additional Details
Clinical Investigator (CI)